Skip to main content
Premium Trial:

Request an Annual Quote

Enzo, Siemens Resolve IP Infringement Case

NEW YORK (GenomeWeb) – Enzo Life Sciences today announced it and Siemens Healthcare Diagnostics have agreed to settle a dispute alleging patent infringement. 

As part of the deal, Siemens will pay Enzo $9.5 million upfront. Enzo is also eligible to receive up to $5 million in licensing fees depending on the sale of additional Siemens products during a five-year period. In return, Enzo discharges Siemens from any claim of infringement of US Patent No. 7,064,197. 

The patent is at the center of a dozen lawsuits that Enzo has filed against competitors alleging infringement of the '197 patent, as well as other patents. The settlement is the second reached by Enzo involving the '197 patent. Earlier this month, Luminex agreed to pay Enzo $7.1 million to settle their dispute.

Enzo Life Sciences is a wholly owned subsidiary of Enzo Biochem.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.